Wave Life Sciences Ltd. (WVE)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Wave Life Sciences Ltd. chart...

About the Company

wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.

$243M

Total Revenue

298

Employees

$775M

Market Capitalization

-10.17

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $WVE News

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12d ago, source:

INHBE lead clinical candidate selected; potential best-in-class treatment for obesity with potent and durable silencing, ...

Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript

11d ago, source:

Q4 2023 Earnings Call Transcript March 6, 2024 Wave Life Sciences Ltd. isn’t one of the 30 most popular stocks among hedge ...

Wave Life Sciences Gains 34% On Narrower Loss In Q4

12d ago, source:

Shares of Wave Life Sciences Ltd. (WVE) are gaining more than 34 percent on Wednesday morning after reporting narrower net loss in ...

Wave Life Sciences: Q4 Earnings Snapshot

12d ago, source:

SINGAPORE — SINGAPORE — Wave Life Sciences Pte. Ltd. (WVE) on Wednesday reported a loss of $16.3 million in its fourth quarter. The Singapore-based company said it had a loss of 15 cents per share.

Wave Life Sciences Ltd earnings beat by $0.08, revenue topped estimates

12d ago, source: Investing

Investing.com - Wave Life Sciences Ltd (NASDAQ: WVE) reported first quarter EPS of $-0.150, $0.08 better than the analyst estimate of $-0.230. Revenue for the quarter came in at $29.06M versus the ...

Wave Life Sciences Ltd. (WVE) Q4 2023 Earnings Call Transcript

12d ago, source: Seeking Alpha

Good morning, and welcome to Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder ...

Wave Life Sciences: Q4 Earnings Snapshot

13d ago, source: Houston Chronicle

SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Wednesday reported a loss of $16.3 million in its fourth quarter. The Singapore-based company said it had a loss of 15 ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...